Arix Bioscience appoints Meghan FitzGerald to Board of Directors
FTSE 250, industry-leading device & formulation business for inhaled airways disease
Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.
Consilium Healthcare - RT @OxfordBioMedica: Oxford BioMedica launches its new beautiful website.
Please take a look around.